Eli Lilly and Co (LLY.US) CEO: The oral weight loss drug is expected to be approved as early as the beginning of next year.

Eli Lilly and Co's CEO David Ricks stated on Monday that the company expects its experimental oral weight loss drug to be approved as early as the beginning of next year.

Zhitong Finance11:27

The arrangement for Trump's inauguration ceremony has been announced: it is expected to cost 0.037 million dollars per minute.

① The inauguration activities of the president-elect Trump in the USA have been announced, including an official party, a MAGA rally, and a large fireworks display, with multiple events taking place at Trump's golf course outside Washington, D.C. ② Trump's inaugural committee has raised over $0.17 billion, expected to reach $0.2 billion, spending $0.037 million per minute, far exceeding the record of $8,600 per minute set during Obama's first inauguration.

cls.cn10:30

Eli Lilly and Co plans to acquire cancer drug developer Scorpion Therapeutics for 2.5 billion dollars.

GlobeNewswire on January 14 | Eli Lilly and Co announced on Monday that it plans to acquire the experimental cancer therapy from Scorpion Therapeutics for up to 2.5 billion dollars in cash, in order to expand its cancer treatment product line. The company will acquire Scorpion's experimental oral therapy STX-478, which is currently undergoing early trials for breast cancer and other advanced solid tumors.

Gelonghui Finance10:23

Obesity Drug Developer Metsera Files for $100M IPO

Seeking Alpha06:54

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires03:08

Market Chatter: Eli Lilly Expects Approval of Experimental Weight-Loss Pill by Early 2026

MT Newswires02:54